Objectives: In this study, we investigated the dose dependence of tick-borne encephalitis virus (TBEV) infection in one of the reservoirs, i.e. Apodemus agrarius, a small rodent species. Methods: The animals were challenged with TBEV per os and intramuscularly with infectious doses ranging from 1 to 1,500 plaque-forming units (pfu). Clinical signs were recorded and clinical and pathological features were evaluated by histological, immunohistochemical, and serological methods. Results: High perorally administered infectious doses resulted in virus replication in the brain, which is the first sign of subclinical viral encephalitis in the Apodemus genus. The animals seroconverted at infectious doses greater than 100 pfu, and all animals remained asymptomatic. Conclusion: Our work shows the first evidence that subclinical TBEV encephalitis may occur in Apodemus species, depending on the virus load of the inoculum. The antiviral response of the local innate immune system may influence the resistance of Apodemus individuals to lower infectious doses. Per oral/nasal infection seems to be more dangerous for the host than other routes of infection.

1.
Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T: TBEV: a review of an emerging zoonosis. J Gen Virol 2009;90:1781-1794.
2.
Leonova GN, Maĭstrovskaia OS: Viremia in patients with tick-borne encephalitis and in persons with attached Ixodes ticks (in Russian). Vopr Virusol 1996;41:224-228.
3.
Balogh Z, Ferenczi E, Szeles K, Gut W, Szomor K, Takács M, Berencsi Gy: Tick-borne encephalitis outbreak due to raw goat milk consumption in Hungary. J Virol Meth 2010;163:481-485.
4.
Kaiser R: Tick-borne encephalitis: clinical findings and prognosis in adults. Wien Med Wochenschr 2012;162:239-243.
5.
Weiner LP, Cole GA, Nathanson N: Experimental encephalitis following peripheral inoculation of West Nile virus in mice of different ages. J Hyg (Lond) 1970;68:435-446.
6.
Kopecky J, Tomkova E, Vlcek M: Immune response of the long tailed field mouse (Apodemus sylvaticus) to tick-borne encephalitis virus infection. Folia Parasitol 1991;38:275-282.
7.
Tonteri E, Kipar A, Voutilainen L, Vene S, Vaheri A, Vapalahti O, Lundkvist Å: The three subtypes of tick-borne encephalitis virus induce encephalitis in a natural host, the bank vole (Myodes glareolus). PLoS One 2013;8:e81214.
8.
Golovljova I, Vene S, Sjölander KB, Vasilenko V, Plyusnin A, Lundkvist A: Characterization of tick-borne encephalitis virus from Estonia. J Med Virol 2004;74:580-588.
9.
Bakhvalova VN, Dobrotvorsky AK, Panov VV, Matveeva VA, Tkachev SE, Morozova OV: Natural tick-borne encephalitis virus infection among wild small mammals in the southeastern part of western Siberia, Russia. Vector Borne Zoonotic Dis 2006;6:32-41.
10.
Környey S: Contribution to the histology of tick-borne encephalitis. Acta Neuropathol 1978;43:179-183.
11.
Vince V, Grcević N: Development of morphological changes in experimental tick-borne meningoencephalitis induced in white mice by different virus doses. J Neurol Sci 1969;9:109-130.
12.
Bagó Z, Bauder B, Kolodziejek J, Nowotny N, Weissenböck H: Tick-borne encephalitis in a mouflon (Ovis ammon musimon). Vet Rec 2002;150:218-220.
13.
Weissenböck H, Suchy A, Holzmann H: Tick-borne encephalitis in dogs: neuropathological findings and distribution of antigen. Acta Neuropathol 1998;95:361-366.
14.
Gelpi E, Preusser M, Garzuly F, Holzmann H, Heinz FX, Budka H: Visualization of Central European tick-borne encephalitis infection in fatal human cases. J Neuropathol Exp Neurol 2005;64:506-512.
15.
Klaus C, Beer M, Saier R, Schubert H, Bischoff S, Süss J: Evaluation of serological tests for detecting tick-borne encephalitis virus (TBEV) antibodies in animals. Berl Munch Tierarztl Wochenschr 2011;124:443-449.
16.
Niedrig M, Klockmann U, Lang W, Roeder J, Burk S, Modrow S, Pauli G: Monoclonal antibodies directed against tick-borne encephalitis virus with neutralizing activity in vivo. Acta Virol 1994;38:141-149.
17.
Labuda M, Austyn JM, Zuffova E, Kozuch O, Fuchsberger N: Importance of localized skin infection in tick-borne encephalitis virus transmission. Virology 1996;219:357-366.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.